​What are the Alpelisib drug interactions?

In 2022, Alpelisib received accelerated FDA approval for patients on the PIK3CA-associated overgrowth disease spectrum, particularly those adults and children over 2 years of age who require systemic therapy, and has shown promising therapeutic outcomes.

What are the Alpelisib drug interactions?

Drug interactions have an important impact on the effectiveness of treatments, and it is critical to understand these interactions.

1. CYP3A4 inducer

Combination of Alpelisib with strong CYP3A4 inducers may reduce drug concentrations and efficacy. Concomitant use of these potent inducers should be avoided, or alternative agents with less effect on CYP3A4 should be chosen.

2. CYP2C9 substrate

Alpelisib may reduce plasma concentrations of CYP2C9 substrates (e.g., warfarin), leading to a weakened effect of these drugs. Plasma concentrations of these substrates should be closely monitored when using Alpelisib.

Patients should be careful to avoid concomitant use of these drugs during the course of medication, and patients should also be aware of the use of drugs in special populations.

Is Alpelisib used for special populations?

Medication in special populations requires special attention. The following are recommendations for the use of Alpelisib in these populations.

1. Pregnancy

Animal studies suggest that Alpelisib may pose potential risks to the fetus, such as embryonic death, weight loss, and malformations. There is a lack of specific risk data on the use of this drug in pregnant women. Pregnant women should avoid the use of Alpelisib.

2. Females and males of reproductive potential

Before using Alpelisib, it should be confirmed that a woman is pregnant. During treatment and for a week after taking the drug, women should use effective contraception, and male partners should also use contraception. Animal studies have shown that the drug may have an effect on fertility.

Special populations should pay attention to closely monitoring drug reactions when using drugs to avoid unnecessary physical injury; It is also important to understand the adverse effects of drugs in order for patients to take them.

What are the adverse effects of Alpelisib?

Adverse reactions may occur during medication, and it is recommended to pay attention to observation and report in time.

1. Fatigue

The use of medications may cause unusual tiredness or weakness, affecting daily activities and quality of life. Long-term fatigue may require treatment adjustments.

2. Hemoglobin is reduced

Medications can cause hemoglobin levels to drop, triggering symptoms of anemia, such as fatigue, dizziness or shortness of breath. Blood markers need to be monitored regularly to prevent severe anemia.

Patients are advised to pay close attention to fatigue and changes in hemoglobin levels, report these adverse reactions to their doctor in a timely manner, and adjust their treatment regimen to prevent serious problems from occurring.

[Warm tips] Pay attention to personal hygiene to avoid infection, especially if the immune system may be affected during treatment.